Benitec Biopharma Inc. Reports Earnings Results for the Full Year Ended June 30, 2021
September 20, 2021 at 08:01 am EDT
Benitec Biopharma Inc. announced earnings results for the full year ended June 30, 2021. For the full year, the company announced total revenue was USD 59,000 compared to USD 102,000 a year ago. Operating loss was USD 13.596 million compared to USD 8.281 million a year ago. Net loss was USD 13.882 million compared to USD 8.274 million a year ago. Basic loss per share from continuing operations was USD 3.23 compared to USD 8.1 a year ago.